MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/iid3.1075

Медицинская библиотека · Immunity, inflammation and disease · 2023

Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation.

Immohr Moritz Benjamin, Oehler Daniel, Jenkins Freya Sophie, Kalampokas Nikolas, Hettlich Vincent Hendrik, Sigetti Dennis, Voß Fabian, Dalyanoglu Hannan, Aubin Hug, Akhyari Payam, Lichtenberg Artur, Boeken Udo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Cytomegalovirus (CMV) infections after heart transplantation (HTx) can cause cardiac allograft vasculopathy. Consequently, monitoring and prophylaxis for cytomegalovirus deoxyribonucleic acid (CMV-DNAemia) within the first weeks after HTx is recommended.

METHODS

All patients who underwent HTx between September 2010 and 2021 surviving the first 90 days (n = 196) were retrospectively reviewed. The patients were divided on the prevalence of CMV-DNAemia during the first postoperative year after the end of the prophylaxis. A total of n = 35 (20.1%) developed CMV-DNAemia (CMV group) and were compared to patients without CMV-DNAemia (controls, n = 139). The remaining patients (n = 22) were excluded due to incomplete data.

RESULTS

Positive donors and negative recipients (D+/R-) and negative donors and positive recipients (D-/R+) serology was significantly increased and D-/R- decreased in the CMV group (p < .01). Furthermore, the mean age was 57.7 ± 8.7 years but only 53.6 ± 10.0 years for controls (p = .03). Additionally, the intensive care unit (p = .02) and total hospital stay (p = .03) after HTx were approximately 50% longer. Interestingly, the incidence of CMV-DNAemia during prophylaxis was only numerically increased in the CMV group (5.7%, respectively, 0.7%, p = .10), the same effect was also observed for postoperative infections. Multivariate analyses confirmed that D+/R- and D-/R+ CMV immunoglobulin G match were independent risk factors for postprophylaxis CMV-DNAemia.

CONCLUSION

Our data should raise awareness of CMV-DNAemia after the termination of regular prophylaxis, as this affects one in five HTx patients. Especially old recipients as well as D+/R- and D-/R+ serology share an elevated risk of late CMV-DNAemia. For these patients, prolongation, or repetition of CMV prophylaxis, including antiviral drugs and CMV immunoglobulins, may be considered.

Для цитирования: Immohr Moritz Benjamin, Oehler Daniel, Jenkins Freya Sophie, Kalampokas Nikolas, Hettlich Vincent Hendrik, Sigetti Dennis, Voß Fabian, Dalyanoglu Hannan, Aubin Hug, Akhyari Payam, Lichtenberg Artur, Boeken Udo. Evaluation of risk factors for cytomegalovirus DNAemia after end of regular prophylaxis after heart transplantation.. Immunity, inflammation and disease. 2023. DOI: 10.1002/iid3.1075.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.